Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Czech Republic cancer and oncology drugs tenders

Get access to latest Czech Republic cancer oncology drugs tenders and government contracts. Find business opportunities for Czech Republic cancer drugs tenders, Czech Republic oncology drugs tenders, Czech Republic cancer treatment drugs tenders.

Summary:
Antibacterial Substances For Systemic Use Xxxvi. - Betalactam Atb
Country:
Czech Republic
Estimated Cost:
EUR 10418000
Notice Type:
Tender Notice
Deadline:
30 Jun 2025
Posting Date:
30 May 2025
 
 
 
Summary:
Serological Analyzers For Separation Hto And Okmi
Country:
Czech Republic
 
Notice Type:
Tender Notice
Deadline:
09 Jun 2025
Posting Date:
29 May 2025
 
 
 
Summary:
Parenteral Nutrition
Country:
Czech Republic
Estimated Cost:
EUR 7609000
Notice Type:
Tender Notice
Deadline:
27 Jun 2025
Posting Date:
28 May 2025
 
 
 
Summary:
A Medicinal Product With The Active Substance Fingolimod
Country:
Czech Republic
Estimated Cost:
EUR 17470000
Notice Type:
Tender Notice
Deadline:
26 Jun 2025
Posting Date:
28 May 2025
 
 
 
Summary:
Medicinal Products - Laxancia, Antidiaroika, Intestinal Anti -Inflammatory And Anti -Infectious Drugs
Country:
Czech Republic
Estimated Cost:
EUR 29396000
Notice Type:
Tender Notice
Deadline:
30 Jun 2025
Posting Date:
28 May 2025
 
 
 
Summary:
Antibacterial Drugs For Systemic Application Ii. 2025
Country:
Czech Republic
Estimated Cost:
EUR 9723653
Notice Type:
Tender Notice
Deadline:
01 Jul 2025
Posting Date:
28 May 2025
 
 
 
Summary:
Drug Supply - The Active Substance Rivaroxaban - Atc B01Af01
Country:
Czech Republic
Estimated Cost:
EUR 12839137
Notice Type:
Tender Notice
Deadline:
27 Jun 2025
Posting Date:
28 May 2025
 
 
 
Summary:
Drug Supply - The Active Substance Golimumab - Atc L04Ab06
Country:
Czech Republic
Estimated Cost:
EUR 17448766
Notice Type:
Tender Notice
Deadline:
27 Jun 2025
Posting Date:
28 May 2025
 
 
 
Summary:
Kardiaka 11. - Levosimendan
Country:
Czech Republic
Estimated Cost:
EUR 5100000
Notice Type:
Tender Notice
Deadline:
04 Jun 2025
Posting Date:
28 May 2025
 
 
 
Summary:
Drug Supply - The Active Substance Apixaban - Atc B01Af02
Country:
Czech Republic
Estimated Cost:
EUR 7756499
Notice Type:
Tender Notice
Deadline:
27 Jun 2025
Posting Date:
28 May 2025